126 results

1.  Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs.
Ramos I, Fernandez-Sesma A.
Front Immunol.  2015-07-20.  DOI:10.3389/fimmu.2015.00361

2.  Assessment of PaO₂/FiO₂ for stratification of patients with moderate and severe acute respiratory distress syndrome.
Villar J, Blanco J, del Campo R, Andaluz-Ojeda D, Díaz-Domínguez FJ, Muriel A, Córcoles V, Suárez-Sipmann F, Tarancón C, González-Higueras E, López J, Blanch L, Pérez-Méndez L, Fernández RL, Kacmarek RM, Spanish Initiative for Epidemiology, Stratification & Therapies for ARDS (SIESTA) Network.
BMJ Open.  2015-03-27.  DOI:10.1136/bmjopen-2014-006812

3.  The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in mice.
van den Berg E, Bal SM, Kuipers MT, Matute-Bello G, Lutter R, Bos AP, van Woensel JB, Bem RA.
Physiol Rep.  2015-03-01.  DOI:10.14814/phy2.12332

4.  Extracorporeal life support for severe acute respiratory distress syndrome.
Leligdowicz A, Fan E.
Curr Opin Crit Care.  2015-02-01.  DOI:10.1097/mcc.0000000000000170

5.  Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.
Bhan U, Podsiad AB, Kovach MA, Ballinger MN, Keshamouni V, Standiford TJ.
PLoS One.  2015-01-30.  DOI:10.1371/journal.pone.0114574

6.  Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
Regla-Nava JA, Nieto-Torres JL, Jimenez-Guardeño JM, Fernandez-Delgado R, Fett C, Castaño-Rodríguez C, Perlman S, Enjuanes L, DeDiego ML.
J Virol.  2015-01-21.  DOI:10.1128/jvi.03566-14

7.  ATF3 protects pulmonary resident cells from acute and ventilator-induced lung injury by preventing Nrf2 degradation.
Shan Y, Akram A, Amatullah H, Zhou DY, Gali PL, Maron-Gutierrez T, González-López A, Zhou L, Rocco PR, Hwang D, Albaiceta GM, Haitsma JJ, dos Santos CC.
Antioxid Redox Signal.  2015-01-19.  DOI:10.1089/ars.2014.5987

8.  Attenuating effect of Ginsenoside Rb1 on LPS-induced lung injury in rats.
Yuan Q, Jiang YW, Ma TT, Fang QH, Pan L.
J Inflamm (Lond).  2014-12-05.  DOI:10.1186/s12950-014-0040-5

9.  Pseudomonas aeruginosa induced lung injury model.
Suresh Kumar V, Sadikot RT, Purcell JE, Malik AB, Liu Y.
J Vis Exp.  2014-10-29.  DOI:10.3791/52044

10.  Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.
Foronjy RF, Dabo AJ, Cummins N, Geraghty P.
BMC Immunol.  2014-10-03.  DOI:10.1186/s12865-014-0041-4

11.  Bone marrow mesenchymal stem cells ameliorates seawater-exposure-induced acute lung injury by inhibiting autophagy in lung tissue.
Liu QP, Zhou DX, Sun L, Ling L, Wu CG, Lin P, Han SP.
Patholog Res Int.  2014-08-19.  DOI:10.1155/2014/104962

12.  β-defensin 2 ameliorates lung injury caused by Pseudomonas infection and regulates proinflammatory and anti-inflammatory cytokines in rat.
Shen Z, Fang L, Zhao L, Lei H.
Int J Mol Sci.  2014-07-30.  DOI:10.3390/ijms150813372

13.  ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury.
Roychaudhuri R, Hergrueter AH, Polverino F, Laucho-Contreras ME, Gupta K, Borregaard N, Owen CA.
J Immunol.  2014-07-25.  DOI:10.4049/jimmunol.1303370

14.  The effect of TIP on pneumovirus-induced pulmonary edema in mice.
van den Berg E, Bem RA, Bos AP, Lutter R, van Woensel JB.
PLoS One.  2014-07-21.  DOI:10.1371/journal.pone.0102749

15.  Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.
Gotts JE, Abbott J, Matthay MA.
Am J Physiol Lung Cell Mol Physiol.  2014-07-18.  DOI:10.1152/ajplung.00110.2014

16.  Analysis of the transcriptome in hyperoxic lung injury and sex-specific alterations in gene expression.
Lingappan K, Srinivasan C, Jiang W, Wang L, Couroucli XI, Moorthy B.
PLoS One.  2014-07-08.  DOI:10.1371/journal.pone.0101581

17.  Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.
Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, Ju X, Liang Z, Liu Q, Zhao Y, Guo F, Bai T, Han Z, Zhu J, Zhou H, Huang F, Li C, Lu H, Li N, Li D, Jin N, Penninger JM, Jiang C.
Nat Commun.  2014-05-06.  DOI:10.1038/ncomms4594

18.  Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria?
Quispe AM, Pozo E, Guerrero E, Durand S, Baldeviano GC, Edgel KA, Graf PC, Lescano AG.
Am J Trop Med Hyg.  2014-04-21.  DOI:10.4269/ajtmh.12-0610

19.  Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.
Zheng G, Huang L, Tong H, Shu Q, Hu Y, Ge M, Deng K, Zhang L, Zou B, Cheng B, Xu J.
Respir Res.  2014-04-04.  DOI:10.1186/1465-9921-15-39

20.  Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives.
Müller-Redetzky HC, Suttorp N, Witzenrath M.
Cell Tissue Res.  2014-03-06.  DOI:10.1007/s00441-014-1821-0